Carvedilol Tablet, Film Coated
Product Images NDC 82804-270

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Carvedilol (NDC 82804-270). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

82804-270-60 (Image 01)

Label for Carvedilol 6.25 mg film-coated tablets, containing 60 tablets per package. The label shows the product name, strength, and dosage form prominently, with the manufacturer listed as Piramal Pharma Limited, India, while the packager is Proficient Rx LP, Thousand Oaks, CA. The tablets are described as white, film-coated, elliptical-shaped, debossed with "TV" on one side and "135" on the other. Storage instructions specify 20°-25°C (68°-77°F).*

FDA Label Image

Structural Formula For Carvedilol (Image 1)

Chemical structure of Carvedilol showing its molecular components, including aromatic rings, hydroxyl, amine, and ether functional groups identifiable in the structure diagram.*

FDA Label Image

Fig 1 (Image 2)

A line graph depicting percent mortality over a 21-month period comparing Carvedilol and placebo. The y-axis shows percentage mortality from 0 to 30%, and the x-axis shows time in months from 0 to 21. The chart illustrates lower mortality with Carvedilol compared to placebo, with a p-value of 0.0014 indicating statistical significance.*

FDA Label Image

Fig 2 (Image 3)

A forest plot illustrating hazard ratios with confidence intervals across various patient subgroups including gender, age, race, diabetic status, ischemic condition, heart rate levels, systolic blood pressure (SBP), and spironolactone use. The horizontal axis represents hazard ratios from 0.0 to 2.0, with a vertical reference line at 1.0.*

FDA Label Image

Fig 3 (Image 4)

A line graph depicting % Mortality over 24 months comparing Carvedilol and Placebo. The graph shows two curves, one labeled 'Carvedilol' and the other 'Placebo,' illustrating mortality trends over time with a p-value of 0.03 indicated on the chart.*

FDA Label Image

Fig 4 (Image 5)

A hazard ratio forest plot depicting multiple subgroup analyses related to myocardial infarction (MI) and associated factors. The graph compares hazard ratios for various patient characteristics such as age, sex, timing of randomization post-MI, prior beta blocker use, Killip class, thrombolytic therapy, PTCA for MI, history of congestive heart failure, diuretic use, angina, hypertension, diabetes, heart rate, and systolic blood pressure, as well as overall patient data. Each subgroup is represented with a plotted point and confidence intervals along a horizontal axis ranging approximately from 0.4 to 1.3.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.